Prostate Cancer Transatlantic Consortium (CaPTC)
Because the problem of prostate cancer disparity persists, it is crucial that we begin to use new paradigms and look at the problem from fresh perspectives to develop effective solutions. The possibility for exploring new paradigms comes from studying Blacks who are connected to the U.S. via the Transatlantic Slave Trade.
The Prostate Cancer Transatlantic Consortium (CaPTC) was formed in 2005 to address the globally disproportionate burden of prostate cancer among Black men. CaPTC is an open consortium comprising a team of prostate cancer scientists, clinicians, survivors, and advocates from North America, Europe, the Caribbean Islands, and West Africa.
CaPTC's research goals are to:
- explore and quantify the magnitude of prostate cancer morbidity and mortality variance among Black men;
- explore the genetic and environmental etiology of this variance, using valid and reliable instruments and biomarkers; and
- develop ethnically sensitive, targeted approaches that will eliminate globally the prostate cancer disparities of Black men through modifiable risk factors associated with prostate cancer.
Administrative leadership of CaPTC comprises the Consortium Director, Scientific Advisory Board, and the Community Advisory Board.
Additionally, members of CaPTC have formed working groups focused on translational research, education and training, and advocacy.
CaPTC organizes biennial conferences on "The Science of Global Prostate Cancer Disparities in Black Men." The 2010 conference was supported by NCI's Division of Cancer Control and Population Sciences (DCCPS) and the Division of Cancer Prevention (DCP). The last conference was held November 1-4, 2012 in Nassau, The Bahamas.
Anyone who is interested in eliminating the worldwide disproportionate burden of prostate cancer in black men can join the CaPTC.
- Damali Martin, Ph.D., M.P.H., Program Director, Host Susceptibility Factors Branch, Epidemiology and Genomics Research Program (EGRP), DCCPS, NCI
- Daniela Seminara, Ph.D., M.P.H., Scientific Consortia Coordinator EGRP, DCCPS, NCI